-
This newly listed firm doubled investors' money in 8 months
The company is an established player globally in sterile injectables and is one of the fastest-growing generic injectable companies
-
Here’s how the Money9 Covid25 index performed this week
Since March 24, 2020, Money9 Covid25 Index has outperformed both Nifty 50 as well as Nifty Pharma indices with a big margin
-
Brokerages see over 30% upside in Gland Pharma; here’s why
Gland Pharma has purchased assets from a biologics company for Rs 90 crore and will be spending around Rs 180 crore additionally to develop & manufact
-
Stocks to watch: Nazara Technologies, HDFC, HCL Technologies, Indiabulls Real Estate, Wipro
Here is the list of top stocks that could be in focus on April 23.
-
Nifty Pharma at record highs, in for a long haul
The Nifty Pharma index closed at record highs of 13,426 gaining 1.29% on Tuesday, while the benchmark Nifty index ended below 14,300-mark at 14,296 af
-
Second wave selloff: Rs 7.6 lakh crore of investor wealth wiped off so far; what’s next?
In FY22 Nifty can deliver 15-20% returns, but before that, it could correct 5-7% or 700-1000 points
